Biomedical Engineering Reference
In-Depth Information
Table 12.2
Summary of clinical trials related to gastrointestinal system (excluded liver and endocrine pancreas) listed on
www.clinicaltrials.gov
in June
2011
Disease
Type of cells
Way of use
Phase I
Phase I/phase II
Phase II
Phase III
Phase IV
Subtotal
Total
Crohn's disease
HSCs
Autologous
1
1
2
1
0
5
12
Allogeneic
0
1
0
0
0
1
BM-MSCs
Autologous
0
0
0
0
0
0
Allogeneic
0
0
2
3
0
5
ASCs
Autologous
0
0
0
0
0
0
Allogeneic
0
0
0
0
0
0
PDSCs
Autologous
0
0
0
0
0
0
Allogeneic
0
0
1
0
0
1
Fistulizing disease
HSCs
Autologous
0
0
0
0
0
0
11
Allogeneic
0
0
0
0
0
0
BM-MSCs
Autologous
0
0
0
0
0
0
Allogeneic
0
1
0
1*
0
1 ± 1
ASCs
Autologous
1
1
4
2
0
8
Allogeneic
0
2
0
0
0
2
Ulcerative colitis
HSCs
Autologous
0
0
0
0
0
0
2
Allogeneic
0
0
0
0
0
0
BM-MSCs
Autologous
0
0
0
0
0
0
Allogeneic
0
0
0
0
0
0
U-MSCs
Autologous
0
0
0
0
0
0
Allogeneic
0
1
0
0
0
1
MAPCs
Autologous
0
0
0
0
0
0
Allogeneic
0
0
1
0
0
1
Fecal incontinence
HSCs
Autologous
0
0
0
0
0
0
1
Allogeneic
0
0
0
0
0
0
BM-MSCs
Autologous
0
0
0
0
0
0
Allogeneic
0
0
0
0
0
0
ASCs
Autologous
1
0
0
0
0
1
Allogeneic
0
0
0
0
0
0
